Author: Barbara W. Unger

Special Report Data Governance

Part 2: Drug GMP Warning Letters Data Governance and Data Integrity

CY2017 data integrity drug GMP warning letters and trends from the past ten years including drug warning letters with data integrity deficiencies, number of data integrity associated warning letters by country, geographic totals and percentage, and regulations cited in 2017 data integrity associated drug warning letters.

Read More »

Can’t find what you are looking for? Contact us.